Literature DB >> 7984430

Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A.

J L Proffitt1, E Sharma, G E Blair.   

Abstract

In highly oncogenic adenovirus (Ad) 12-transformed cells, major histocompatibility complex (MHC) class I gene expression is down-regulated by the products of the viral E1A oncogene at the level of initiation of transcription. However, class I gene expression is unaltered or elevated in non-oncogenic Ad2- or Ad5-transformed cells. These changes in class I expression may permit Ad12-transformed cells to escape host immune surveillance and elicit tumour formation. Here we show that the 2kb of 5' flanking region of the mouse H-2Kb class I gene is sufficient to mediate down-regulation of transcription driven from homologous or heterologous (HSV thymidine kinase) basal promoter elements in cells expressing Ad12 E1A, but not in Ad2 E1A-expressing cells. Deletion analysis of the 2kb region showed that sequences from -1.18 to -1.44kb (relative to the cap site) were a target for Ad12 E1A-mediated transcriptional down-regulation. Deletion of this entire region from the 2kb flanking sequence of the H-2Kb gene abolished Ad12 E1A-mediated down-regulation of transcription. Computer analysis of the -1.18 to -1.44kb sequence identified two 6/7bp matches with the AP-1 transcription factor consensus sequence and two matches with the pig MHC class I PD1 repressor element. Gel retardation analysis using overlapping DNA fragments derived from the -1.18 to -1.44kb sequence revealed several DNA:protein complexes formed using nuclear extract derived from Ad12-, but not from Ad2- or Ad5-transformed cells. Some of these DNA:protein complexes were also present, but at lower levels, in nuclear extracts from untransformed rat cells suggesting the possible involvement of cellular factors in the mechanism of down-regulation mediated by Ad12 E1A. A binding site for the AP-1 factor failed to compete for protein binding to fragments within the -1.18 to -1.44 sequence, while the PD1 site competed for binding only in the -1.15 to -1.23 region. These results indicate that novel factors (as well as a previously identified class I repressor, PD1) may be involved in Ad12 E1A-mediated down-regulation of MHC class I transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984430      PMCID: PMC308530          DOI: 10.1093/nar/22.22.4779

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Reduced binding activity of transcription factor NF-kappa B accounts for MHC class I repression in adenovirus type 12 E 1-transformed cells.

Authors:  I Meijer; A J Boot; G Mahabir; A Zantema; A J van der Eb
Journal:  Cell Immunol       Date:  1992-11       Impact factor: 4.868

2.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  A complex regulatory DNA element associated with a major histocompatibility complex class I gene consists of both a silencer and an enhancer.

Authors:  J D Weissman; D S Singer
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Striking similarities between the regulatory mechanisms governing yeast mating-type genes and mammalian major histocompatibility complex genes.

Authors:  J D Weissman; D S Singer
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  A novel function of the transforming domain of E1a: repression of AP-1 activity.

Authors:  R Offringa; S Gebel; H van Dam; M Timmers; A Smits; R Zwart; B Stein; J L Bos; A van der Eb; P Herrlich
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

6.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

Review 7.  Adenovirus E1a as a tumor-suppressor gene.

Authors:  G Chinnadurai
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

8.  Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.

Authors:  R Ge; A Kralli; R Weinmann; R P Ricciardi
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element.

Authors:  A Kralli; R Ge; U Graeven; R P Ricciardi; R Weinmann
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells.

Authors:  U Nielsch; S G Zimmer; L E Babiss
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  4 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Transcriptional regulation of MHC class I gene expression in rat oligodendrocytes.

Authors:  G Mavria; K T Hall; R A Jones; G E Blair
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

Authors:  N Lee; M Llano; M Carretero; A Ishitani; F Navarro; M López-Botet; D E Geraghty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms.

Authors:  Amie J Eisfeld; Michael B Yee; Angela Erazo; Allison Abendroth; Paul R Kinchington
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.